UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Allocating to a wide market index fund for retirement aims to spread risk across the market, supporting steady growth while keeping fees reasonable.
28,235 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
If the CLARITY Act clears Congress, crypto assets could be reclassified into three buckets, altering enforcement, lis...
U.S. equities sit near record highs as AI spending fuels gains, but a growing chorus on Wall Street warns that federa...
Midas’ mglobal token tracking makes its way onto Aave Horizon as Fasanara unrolls an alternative debt strategy, allow...
South Korea revealed a sweeping $590 billion plan to boost memory chips and AI hardware, triggering gains in semicond...
Teladoc has faced a challenging stretch after its pandemic boom. This guide examines whether teladoc stock going read...
Solv Protocol confirms a crypto exploit drained about $2.7 million from a Bitcoin yield vault, impacting roughly 10 u...
Ready to dip a modest $100 into crypto? This guide breaks down two strong bets—Solana and Cardano—and shows how to ev...
Bitcoin stays above $81,000 as geopolitical strains involving Iran collide with crypto flows. A $1 billion ETH unwind...
Jeff Bezos publicly challenged Elon Musk's plan for space-based data centers, calling the proposed timeline likely to...
XRP rose about 2% as ETF inflows persisted, signaling continued institutional demand even as broader markets stay vol...
Micron stock has faced a pullback as market focus shifts from AI optimism to risk management. This article breaks dow...